Ohio State System-Wide Medication for Opioid Use Disorder (SW-MOUD) Program

This program makes medication for opioid use disorder available throughout the healthcare system

Medication for opioid use disorder (MOUD) is an evidence-based treatment for opioid use disorder (OUD) but access to MOUD is often limited, making it difficult to assist patients needing addiction treatment during health care encounters. To increase access, the Ohio State Wexner Medical Center designed the System-Wide MOUD (SW-MOUD) program, which has two objectives, (a) expand access to MOUD across emergency, inpatient, and outpatient settings, and (b) coordinate care for patients across these settings using integrated program staff.

As described in a presentation on SW-MOUD, healthcare settings connected by the program include emergency departments, inpatient hospitals, ambulatory specialty clinics, and primary care practices. Patient care across settings is facilitated by social workers, peer support staff, and dedicated MOUD care coordinators, maximizing the chances that addiction services are accessible and maintained throughout the system. A journal article describes program implementation and operations, suggesting that SW-MOUD is a viable model for increasing access to addiction treatment. Contact information for the program is available at the Ohio State Wexner Medical Center website.

Providing evidence-based opioid treatment throughout the healthcare system increases the chances that opioid addicted patients get the help they need.

Continuum of Care
Treatment
Type of Evidence
Peer-reviewed
Response Approach
Medications for Opioid Use Disorder
Peer-reviewed Article

Evidence of Program Effectiveness

"In the program's first 4 years, there were a total of 4,908 MOUD initiations...The SW-MOUD program implementation [can] serve as a roadmap for the creation of similar care delivery mechanisms...The transformation of evidence-based treatments into systematic delivery approaches offers the potential to improve patient outcomes" O'Rourke et al. 2025.